Healthcare provider profile · identity verified

Peter M Colucio, MD

Internal Medicine · BERKELEY HEIGHTS, NJ · NPI 1184625287

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	683	192
Amlodipine Besylate	Amlodipine Besylate	312	90
Lisinopril	Lisinopril	235	69
Rosuvastatin Calcium	Rosuvastatin Calcium	199	60
Zolpidem Tartrate	Zolpidem Tartrate	186	39
Losartan Potassium	Losartan Potassium	183	51
Alprazolam	Alprazolam	180	58
Metformin Hcl Er	Metformin Hcl	138	43
Hydrochlorothiazide	Hydrochlorothiazide	137	36
Levothyroxine Sodium	Levothyroxine Sodium	130	37
Metoprolol Succinate	Metoprolol Succinate	129	37
Allopurinol	Allopurinol	110	30
Fluticasone Propionate	Fluticasone Propionate	93	37
Ezetimibe	Ezetimibe	84	33
Sertraline Hcl	Sertraline Hcl	77	20
Escitalopram Oxalate	Escitalopram Oxalate	75	22
Tamsulosin Hcl	Tamsulosin Hcl	74	24
Metformin Hcl	Metformin Hcl	72	19
Simvastatin	Simvastatin	70	22
Gabapentin	Gabapentin	69	11
Valsartan	Valsartan	62	18
Glimepiride	Glimepiride	56	17
Telmisartan	Telmisartan	56	15
Omeprazole	Omeprazole	55	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	15
Irbesartan	Irbesartan	50	11
Olmesartan Medoxomil	Olmesartan Medoxomil	50	13
Lorazepam	Lorazepam	49	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	45	12
Pravastatin Sodium	Pravastatin Sodium	43	12
Pantoprazole Sodium	Pantoprazole Sodium	42	14
Synthroid	Levothyroxine Sodium	42	13
Trazodone Hcl	Trazodone Hcl	41	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	37	11
Meloxicam	Meloxicam	34	suppressed
Benazepril Hcl	Benazepril Hcl	32	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	32	suppressed
Valacyclovir	Valacyclovir Hcl	31	13
Azelastine Hcl	Azelastine Hcl	29	17
Famotidine	Famotidine	29	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Azithromycin	Azithromycin	28	28
Montelukast Sodium	Montelukast Sodium	28	suppressed
Atenolol	Atenolol	27	suppressed
Eliquis	Apixaban	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	22
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	25	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	23	suppressed
Diazepam	Diazepam	22	suppressed
Furosemide	Furosemide	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Potassium Chloride	Potassium Chloride	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Colchicine	Colchicine	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Finasteride	Finasteride	19	suppressed
Naproxen	Naproxen	19	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Jardiance	Empagliflozin	17	suppressed
Nebivolol Hcl	Nebivolol Hcl	17	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Methylprednisolone	Methylprednisolone	16	15
Mometasone Furoate	Mometasone Furoate	16	suppressed
Ramipril	Ramipril	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	13	suppressed
Tadalafil	Tadalafil	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Linzess	Linaclotide	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Methylphenidate Er	Methylphenidate Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error